Education
About Us
Working with TipRanks
Follow Us
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Total Valuation
COSMOS Pharmaceutical Corporation has a market cap or net worth of ¥698.09B. The enterprise value is ¥692.92B.
Market Cap¥698.09B
Enterprise Value¥692.92B
Share Statistics
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,001,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
COSMOS Pharmaceutical Corporation’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.47%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)9.47%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee183.49M
Profits Per Employee5.62M
Employee Count5,512
Asset Turnover1.93
Inventory Turnover8.64
Valuation Ratios
The current PE Ratio of COSMOS Pharmaceutical Corporation is 22.4. COSMOS Pharmaceutical Corporation’s PEG ratio is 0.85.
PE Ratio22.4
PS Ratio0.69
PB Ratio2.72
Price to Fair Value2.72
Price to FCF-814.90
Price to Operating Cash Flow0.00
PEG Ratio0.85
Income Statement
In the last 12 months, COSMOS Pharmaceutical Corporation had revenue of 1.01T and earned 30.98B in profits. Earnings per share was 390.85.
Revenue1.01T
Gross Profit213.28B
Operating Income40.40B
Pretax Income42.37B
Net Income30.98B
EBITDA64.86B
Earnings Per Share (EPS)390.85
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
COSMOS Pharmaceutical Corporation pays an annual dividend of ¥37.5, resulting in a dividend yield of 0.81%
Dividend Per Share¥37.5
Dividend Yield0.81%
Payout Ratio17.91%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.30
52-Week Price Change21.07%
50-Day Moving Average9.21K
200-Day Moving Average8.23K
Relative Strength Index (RSI)37.04
Average Volume (3m)293.99K
Important Dates
COSMOS Pharmaceutical Corporation upcoming earnings date is Oct 8, 2025, TBA (Confirmed).
Last Earnings DateJul 11, 2025
Next Earnings DateOct 8, 2025
Ex-Dividend DateNov 27, 2025
Financial Position
COSMOS Pharmaceutical Corporation as a current ratio of 0.75, with Debt / Equity ratio of 19.40%
Current Ratio0.75
Quick Ratio0.33
Debt to Market Cap0.06
Net Debt to EBITDA-0.11
Interest Coverage Ratio159.07
Taxes
In the past 12 months, COSMOS Pharmaceutical Corporation has paid 11.39B in taxes.
Income Tax11.39B
Effective Tax Rate0.27
Enterprise Valuation
COSMOS Pharmaceutical Corporation EV to EBITDA ratio is 10.68, with an EV/FCF ratio of -806.66.
EV to Sales0.69
EV to EBITDA10.68
EV to Free Cash Flow-806.66
EV to Operating Cash Flow13.21
Balance Sheet
COSMOS Pharmaceutical Corporation has ¥57.04B in cash and marketable securities with ¥49.96B in debt, giving a net cash position of ¥7.08B billion.
Cash & Marketable Securities¥57.04B
Total Debt¥49.96B
Net Cash¥7.08B
Net Cash Per Share¥88.51
Tangible Book Value Per Share¥3.24K
Margins
Gross margin is 21.09%, with operating margin of 3.99%, and net profit margin of 3.06%.
Gross Margin21.09%
Operating Margin3.99%
Pretax Margin4.19%
Net Profit Margin3.06%
EBITDA Margin6.41%
EBIT Margin4.21%
Analyst Forecast
The average price target for COSMOS Pharmaceutical Corporation is ¥10,645.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥10,645.67
Price Target Upside21.39% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast4.81%
EPS Growth Forecast26.65%